AI Digital Dermatoscopy

AI digital dermatoscopy combines two ideas: dermatoscopy, which is the magnified examination of the skin, and digital imaging analysed with the help of artificial intelligence. A dermatoscope magnifies a mole many times over, often in the range of 10 to 100 times, revealing patterns of colour and structure beneath the surface that are invisible to the naked eye. The images are stored digitally with the lesion's location mapped on the body, and AI software analyses them to flag features that may warrant attention and to assist with a risk assessment. Crucially, this is a decision-support tool. It complements the dermatologist's expertise rather than replacing the clinical judgement that leads to a diagnosis.

During the visit the dermatologist passes a handheld dermatoscope over the moles of concern, or over the whole skin surface, capturing high-resolution photographs. The software organises these images on a map of the body so each mole can be found again later, and the AI analyses the patterns within each lesion, drawing the clinician's attention to anything irregular and helping to assign a risk level. Because the images are archived, the same moles can be re-photographed at later visits and compared side by side, so even the smallest change in size, shape or colour stands out. The whole process is photographic and contactless, with no cutting and nothing to recover from. If a lesion looks suspicious, the dermatologist may recommend a biopsy to confirm.

The main purpose is the early detection and monitoring of skin cancer, particularly melanoma, where catching change early matters greatly. It is especially useful for people who have many moles, atypical or irregular moles, moles that are changing, or a personal or family history of melanoma, as well as anyone wanting careful long-term skin surveillance. By documenting moles precisely and comparing them over time, it helps separate harmless changes from those that need action, which can reduce unnecessary removals while catching concerning lesions sooner. It is a screening and monitoring aid, not a standalone diagnosis, so its findings are always reviewed by a dermatologist who decides whether further tests are needed.

The key benefits are precision, consistency and reassurance. Mapping and archiving moles allows objective comparison over time, the AI provides an additional layer of analysis to support the clinician, and the examination is quick, painless and completely non-invasive, with no needles, no radiation and no downtime. You simply have the moles or skin photographed, and the dermatologist discusses the findings with you. For ongoing surveillance, regular follow-up imaging is usually advised so changes can be tracked. If anything looks suspicious, the next step is typically a simple biopsy. The value lies in expert interpretation, so the imaging is most useful as part of a consultation with a dermatologist.